<?xml version="1.0" encoding="UTF-8"?>
<ref id="B135-pharmaceuticals-13-00283">
 <label>135.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Donovan</surname>
    <given-names>L.</given-names>
   </name>
   <name>
    <surname>Welford</surname>
    <given-names>S.M.</given-names>
   </name>
   <name>
    <surname>Haaga</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>LaManna</surname>
    <given-names>J.</given-names>
   </name>
   <name>
    <surname>Strohl</surname>
    <given-names>K.P.</given-names>
   </name>
  </person-group>
  <article-title>Hypoxia-implications for pharmaceutical developments</article-title>
  <source>Sleep Breath.</source>
  <year>2010</year>
  <volume>14</volume>
  <fpage>291</fpage>
  <lpage>298</lpage>
  <pub-id pub-id-type="doi">10.1007/s11325-010-0368-x</pub-id>
  <pub-id pub-id-type="pmid">20625934</pub-id>
 </element-citation>
</ref>
